Purchase Order HHSN268201700296A
Award Date
8/25/17
Potential Completion Date
8/27/18
Potential Value
$81K
Federal Agency
National Heart Lung and Blood Institute
Awardee
Second Genome, Inc.
Ultimate Awardee
Not listed
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
South San Francisco, CA 94080, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), awarded a $10,620 firm fixed price purchase order to Proteogenix, a for-profit manufacturer of biotechnology products and services. The contract provides additional laboratory screening services to support the development of novel gene therapy by the NHLBI's Center for Molecular Therapeutics and Bioanalytics (CMTB). This award is not associated with a larger contract vehicle and does not have...
The National Heart, Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), has awarded a $42,427 firm fixed price delivery order contract to Illumina, Inc. to provide reagents and kits necessary for next-generation sequencing on laboratory instruments in support of NHLBI-funded investigators. The place of performance is Illumina's facilities in San Diego, California. The period of performance is one month,...
The National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. government, awarded a $229,104 firm fixed-price purchase order contract to Psomagen Inc., a for-profit organization and manufacturer of goods. The contract, which has no set-aside designation, is for investigating transthyretin (TTR) variants and their impact on sickle cell disease severity using Olink proteomics technology. This contract is part of a larger $500 million single-award Indefinite Delivery...
The National Heart Lung and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH), awarded a $34,966 firm fixed-price purchase order to Mission Bio, Inc., a for-profit manufacturer of biological supplies and sequencing services. The contract is for the delivery of Tapestri Single-Cell DNA + Protein Reagent Kits to support NHLBI's biomedical research and genomics efforts. The contract has a performance period through December 19, 2025 and does not utilize any...
The National Heart, Lung and Blood Institute (NHLBI), part of the National Institutes of Health within the Department of Health and Human Services, awarded a firm fixed price delivery order valued at $41,507.66 to Illumina, Inc. of San Diego, California. The purpose of this order is to provide reagent kits that are required by the NHLBI Sequencing Core Facility to carry out next-generation sequencing in support of Institute-funded investigators. Work will be performed in San Diego through...
The National Heart, Lung and Blood Institute (NHLBI) has awarded a $14,097.60 firm fixed price purchase order to Psomagen Inc., a for-profit organization and manufacturer of goods, to provide transcriptome profiling of human bone marrow core samples. The work supports the Hematology Branch at NHLBI. This is not a set-aside contract. Psomagen Inc. is a subsidiary of Macrogen, Inc. and operates CLIA-certified and CAP-accredited facilities. The company has a $500 million single-award Indefinite...
The National Heart Lung and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH), awarded a $17,000.00 firm fixed-price purchase order to Synthego Corporation, a self-certified small disadvantaged business and manufacturer of gene editing products. The contract is for knock-out cell line generation services to support the agency's cell biology experiments. No set-aside designation was used. Synthego, a leading provider of advanced genetic engineering tools...
The National Heart Lung and Blood Institute (NHLBI), a civilian agency under the National Institutes of Health (NIH), awarded a $31,567.82 firm fixed price delivery order contract to Illumina, Inc., a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis. The contract is for DNA library preparation kits to support next-generation DNA sequencing and library preparation for the NHLBI's DNA Sequencing Core to assist investigators. This contract does...
The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute (HHS-NIH-NHLBI) awarded a $156,707 purchase order to Illumina, Inc. to renew an existing Illumina service contract. The one-year firm fixed price contract will provide ongoing services in support of the NHLBI's research programs from June 2021 through June 2022. Illumina will perform the work as the prime contractor in San Diego, California. No subcontractors or set aside...
The National Heart, Lung, and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH), awarded a $11,495 firm fixed-price purchase order to GSL Biotech, LLC (doing business as Snapgene), a self-certified small disadvantaged business. The contract is for the renewal of a 110-user annual subscription to Snapgene software, which supports over 80 NHLBI researchers across multiple divisions in conducting molecular cloning procedures. Snapgene is a specialized...